long
term
tobramycin
therapy
patients
cystic
fibrosis
advanced
pulmonary
disease
aim
clinical
study
find
prolonged
tobramycin
therapy
prevent
rapid
deterioration
cystic
fibrosis
patients
eleven
courses
treatment
given
nine
patients
eight
markedly
improved
physical
activity
gained
weight
however
four
patients
clinical
improvement
correlated
improved
radiogram
pseudomonas
eradicated
sputum
four
patients
therapy
reappeared
three
end
therapy
clinical
improvement
negligible
side
effects
suggest
treatment
exacerbating
pyocyaneus
bronchopneumonia
prolonged
tobramycin
therapy
dosage
higher
mg
kg
day
strict
control
tobramycin
blood
level
awareness
side
effects
